Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Case: Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant musculoskeletal disorder with progressive heterotopic ossification within soft connective tissues causing ankyloses and unique skeletal malformations of the big toes, which represent a birth hallmark for the disease. The classic variant is c.617G>A (p.Arg206His). We report 2 atypical FOP cases showing severe digit reduction, associated with a c.983G>A (p.Gly328Glu) variant in exon 8 of the ACVR1 gene.
Conclusion: FOP should be ruled out in patients presenting with restricted movements of joints and spine and reduction of digits by clinical examination and molecular genetic analysis to allow preventive steps and slow clinical deterioration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2106/JBJS.CC.25.00226 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Atypical Fibrodysplasia Ossificans Progressiva with G328E Variant and Digit Reduction Abnormalities: A Report of 2 Cases.
JBJS Case Connect
July 2025
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India.
Case: Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant musculoskeletal disorder with progressive heterotopic ossification within soft connective tissues causing ankyloses and unique skeletal malformations of the big toes, which represent a birth hallmark for the disease. The classic variant is c.617G>A (p.
View Article and Find Full Text PDFMonoallelic variants in ACVR1 in a cohort of Egyptian individuals with fibrodysplasia ossificans progressiva.
Clin Dysmorphol
April 2025
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo.
Objectives: Fibrodysplasia ossificans progressiva (FOP) is a rare ectopic ossification disorder of connective tissue deposited in the muscles, fascia, tendons, and ligaments. The disease is an autosomal dominant pattern caused by pathogenic variants of ACVR1. Herein, we describe the largest number of affected individuals from the Middle East North Africa region who presented with FOP.
View Article and Find Full Text PDFSingle-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cells.
Am J Hum Genet
September 2025
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, HSE 901, San Francisco, CA 94143-0794, USA; UCSF Program in Craniofacial Biology, the UCSF Institute for Human Genetics, and the Eli and Edythe Broad Institute for Regener
Genetic mosaicism is a leading cause of human disease across the lifespan. Improving the tools to detect somatic mosaicism and applying them to understand the cellular and molecular mechanisms that contribute to disease is of critical importance for improving human health. Fibrous dysplasia (FD) is a prototypical disease of G-GPCR activation caused by somatic, mosaic GNAS variants (c.
View Article and Find Full Text PDFFibrous dysplasia/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic/translational research.
Orphanet J Rare Dis
August 2025
Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, Rome, 00161, Italy.
Fibrous dysplasia/McCune Albright syndrome (FD/MAS) is a rare genetic disease caused by postzygotic activating variants in the GNAS gene, encoding the α subunit of stimulatory G protein (Gα). Although multiple organs may be involved, skeletal lesions usually represent the most severe and least treatable expression of the disease, leading to bone deformities, spontaneous fractures, and chronic pain that severely reduce patients' quality of life.The recognition of the causative Gα variants and the consequent ligand-independent activation of the adenylyl cyclase/cAMP/PKA pathway has provided a clear molecular explanation to most extra-skeletal pathologies of FD/MAS, leading to the development of effective therapeutic approaches.
View Article and Find Full Text PDFAssessing the economic burden and health-related quality of life in chinese patients with fibrodysplasia ossificans progressiva: a questionnaire survey analysis.
Orphanet J Rare Dis
August 2025
School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, 300072, China.
Background: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, disabling genetic disorder condition that lacks real-world evidence on disease burden. This study aims to investigate the basic characteristics, diagnostic status, prognosis, economic burden and quality of life of FOP patients in China through self-reported data .
Methods: An online survey was conducted through the "China Cloud Platform for Rare Diseases" among patients recruited from the FOP patient organization in March 2023.